全文获取类型
收费全文 | 3559篇 |
免费 | 170篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 72篇 |
妇产科学 | 40篇 |
基础医学 | 463篇 |
口腔科学 | 86篇 |
临床医学 | 214篇 |
内科学 | 909篇 |
皮肤病学 | 20篇 |
神经病学 | 284篇 |
特种医学 | 106篇 |
外科学 | 752篇 |
综合类 | 7篇 |
预防医学 | 102篇 |
眼科学 | 15篇 |
药学 | 278篇 |
中国医学 | 3篇 |
肿瘤学 | 362篇 |
出版年
2023年 | 9篇 |
2022年 | 17篇 |
2021年 | 33篇 |
2020年 | 25篇 |
2019年 | 44篇 |
2018年 | 42篇 |
2017年 | 39篇 |
2016年 | 33篇 |
2015年 | 60篇 |
2014年 | 61篇 |
2013年 | 88篇 |
2012年 | 105篇 |
2011年 | 130篇 |
2010年 | 73篇 |
2009年 | 61篇 |
2008年 | 115篇 |
2007年 | 142篇 |
2006年 | 147篇 |
2005年 | 159篇 |
2004年 | 146篇 |
2003年 | 160篇 |
2002年 | 170篇 |
2001年 | 147篇 |
2000年 | 158篇 |
1999年 | 197篇 |
1998年 | 58篇 |
1997年 | 55篇 |
1996年 | 73篇 |
1995年 | 59篇 |
1994年 | 54篇 |
1993年 | 36篇 |
1992年 | 137篇 |
1991年 | 131篇 |
1990年 | 120篇 |
1989年 | 113篇 |
1988年 | 130篇 |
1987年 | 81篇 |
1986年 | 77篇 |
1985年 | 68篇 |
1984年 | 62篇 |
1983年 | 27篇 |
1982年 | 10篇 |
1981年 | 10篇 |
1980年 | 9篇 |
1979年 | 26篇 |
1978年 | 10篇 |
1977年 | 14篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1968年 | 2篇 |
排序方式: 共有3737条查询结果,搜索用时 15 毫秒
101.
Takagi Y Saitoh S Tanaka S Shimamoto K 《Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics》1998,35(11):830-838
The present report describes the relationship between the glucose tolerance and hypertension surveyed in a ten-year longitudinal epidemiological study in two rural communities in Hokkaido, Japan. The 1972 subjects (928 men and 1044 women, aged 40-64, mean 51.1 +/- 7.0 years) were randomly selected in 1977 and 1978, underwent a 50-g oral glucose tolerance test (GTT) at the first year. The prevalences of borderline hypertension (BHT) and of hypertension (HT) were highest in those with diabetes mellitus (DM), followed by those with borderline diabetes (BDM) and those normal glucose tolerance (NGT). Systolic and diastolic blood pressure were significantly and positively correlated with plasma glucose levels during fasting (FPG), 60 min. after GTT (60G), and 120 min. after GTT (120G), and were ordered as follows: NGT < BDM < DM. The FPG, 60G and 120G plasma glucose levels were all significantly higher in BHT and HT than in NT. The prevalences of the progression to hypertension from non-hypertension over the ten-year follow-up period were ordered as follows: NGT < BDM < DM. Glucose levels in progression group were higher than those in non-progression group. Multiple logistic regression analysis indicated that age, glucose intolerance, systolic blood pressure, and obesity index were significant predictors of the progression to hypertension. These results indicate that impaired glucose tolerance may be associated with hypertension, and might play a role in the development of hypertension. 相似文献
102.
Takaki S Tsubota A Hosaka T Akuta N Someya T Kobayashi M Suzuki F Suzuki Y Saitoh S Arase Y Ikeda K Kumada H 《Journal of gastroenterology》2004,39(7):668-673
Background Recent studies indicate that combination therapy with ribavirin and interferon alfa2b (IFN2b) is effective for chronic hepatitis C virus (HCV) infection. However, reversible hemolytic anemia is a common side effect of this therapy.Methods We determined those factors that contribute to ribavirin dose reduction due to anemia during this treatment by using multiple logistic regression analysis in Japanese patients. The study included 123 patients with chronic hepatitis C (85 male, 38 female; mean age, 50 years; range, 20–70 years), who received 24-week combination therapy. All patients were treated with IFN2b daily for 2 weeks, followed by three times weekly dosing for 22 weeks, with oral ribavirin twice daily, at a total daily dose of 600 or 800mg.Results Of the 123 patients, 34 patients required dose reduction of ribavirin, and 78 patients required no dose reduction. Overall, 20 patients discontinued. On univariate analysis, reduction of the ribavirin dose correlated significantly with pretreatment hemoglobin (Hb) levels of less than 14g/dl, female sex, and patient age 55 years or older. On multivariate analysis, pretreatment Hb of less than 14g/dl level and age 55 years or older were significantly associated with ribavirin dose reduction. The hazard ratios were 3.56 (95% confidence interval [CI], 1.48–8.53) for pretreatment Hb levels of less than 14g/dl, and 2.50 (95% CI, 1.05–5.94) for age 55 years or more.Conclusions Because patient age of 55 years or more, and Hb levels of less than 14g/dl are significant factors that influence ribavirin-induced hemolytic anemia, more careful monitoring is necessary during combination therapy for patients with these risk factors. 相似文献
103.
Takeshi Asano Hidehiko Narazaki Kiyohiko Kaizu Shouhei Matsukawa Yuki Takema‐Tochikubo Shuichi Fujii Nobuyuki Saitoh Kunihiko Mashiko Osamu Fujino 《Pediatrics international》2015,57(5):988-990
Although thrombotic thrombocytopenic purpura (TTP) is rare, early diagnosis and treatment are important for decreasing the mortality rate. Acquired vitamin B12 deficiency is frequently overlooked because of its rarity in developed countries, particularly in children and adolescents. The hematological changes in vitamin B12 deficiency present as megaloblastic anemia, increased lactate dehydrogenase, vasoconstriction, increased platelet aggregation, and abnormal activation of the coagulation followed by microangiopathy as well as neutropenia and thrombocytopenia. We report herein the case of a 15‐year‐old girl who had been neglected, which might have caused pseudo‐TTP through malnutrition, particularly vitamin B12 deficiency. When we encounter cases of TTP in children, clinicians must be aware of the possibility of malnutrition, particularly with vitamin B12 deficiency, even in developed countries, and investigate the cause of malnutrition including neglect. 相似文献
104.
105.
Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese 总被引:15,自引:0,他引:15
Daimon M Oizumi T Saitoh T Kameda W Yamaguchi H Ohnuma H Igarashi M Manaka H Kato T 《Diabetes research and clinical practice》2002,56(2):147-152
A G-to-A (UCSNP-43) polymorphism of the calpain-10 gene was significantly associated with type 2 diabetes (DM) in Mexican-American, and was postulated, together with a T-to-C (UCSNP-44) polymorphism, as a risk factor for DM. We examined the association of these genotypes with DM in Japanese. Eighty-one subjects with DM and 81 non-diabetic subjects (NGT) were recruited. The number of subjects with genotypes UCSNP-43 G/G, G/A and A/A were 76, 5 and 0, respectively, for the DM and NGT groups. The number of subjects with genotypes UCSNP-44 T/T, T/C and C/C were 66, 14 and 1 for the DM group and 64, 17 and 0 for the NGT group. There was no difference between the groups in terms of frequency of any genotype combinations. No association between the genotypes and DM was observed. We next examined the differences between the genotypes or genotype combinations in terms of the traits related to DM, obesity, hypertension and dyslipidemia. No differences were observed between the genotypes UCSNP43 G/G and G/A, between UCSNP-44 T/T and the others, or between the genotype combination UCSNP-43 G/G and UCSNP-44 T/T and the others, except that the individuals with the genotype combination had significantly increased serum cholesterol levels (212.6 +/- 34.3 vs. 198.5 +/- 29.9, P=0.020). The genotype combination might be a risk factor, not for DM, obesity and hypertension, but for increased serum cholesterol. 相似文献
106.
Yuta Aizawa Kanako Watanabe Tomohiro Oishi Harunobu Hirano Isao Hasegawa Akihiko Saitoh 《Emerging infectious diseases》2015,21(11):1966-1972
Human parechovirus type 3 (HPeV3) is an emerging pathogen that causes sepsis and meningoencephalitis in young infants. To test the hypothesis that maternal antibodies can protect this population, we measured neutralizing antibody titers (NATs) to HPeV3 and other genotypes (HPeV1 and HPeV6) in 175 cord blood samples in Japan. The seropositivity rate (>1:32) for HPeV3 was 61%, similar to that for the other genotypes, but decreased significantly as maternal age increased (p<0.001). Furthermore, during the 2014 HPeV3 epidemic, prospective measurement of NATs to HPeV3 in 45 patients with severe diseases caused by HPeV3 infection showed low NATs (<1:16) at onset and persistently high NATs (>1:512) until age 6 months. All intravenous immunoglobulin samples tested elicited high NATs to HPeV3. Our findings indicate that maternal antibodies to HPeV3 may help protect young infants from severe diseases related to HPeV3 and that antibody supplementation may benefit these patients. 相似文献
107.
Haruno Nishimuro Hirofumi Ohnishi Midori Sato Mayumi Ohnishi-Kameyama Izumi Matsunaga Shigehiro Naito Katsunari Ippoushi Hideaki Oike Tadahiro Nagata Hiroshi Akasaka Shigeyuki Saitoh Kazuaki Shimamoto Masuko Kobori 《Nutrients》2015,7(4):2345-2358
Quercetin is a promising food component, which can prevent lifestyle related diseases. To understand the dietary intake of quercetin in the subjects of a population-based cohort study and in the Japanese population, we first determined the quercetin content in foods available in the market during June and July in or near a town in Hokkaido, Japan. Red leaf lettuce, asparagus, and onions contained high amounts of quercetin derivatives. We then estimated the daily quercetin intake by 570 residents aged 20–92 years old in the town using a food frequency questionnaire (FFQ). The average and median quercetin intakes were 16.2 and 15.5 mg day−1, respectively. The quercetin intakes by men were lower than those by women; the quercetin intakes showed a low correlation with age in both men and women. The estimated quercetin intake was similar during summer and winter. Quercetin was mainly ingested from onions and green tea, both in summer and in winter. Vegetables, such as asparagus, green pepper, tomatoes, and red leaf lettuce, were good sources of quercetin in summer. Our results will help to elucidate the association between quercetin intake and risks of lifestyle-related diseases by further prospective cohort study and establish healthy dietary requirements with the consumption of more physiologically useful components from foods. 相似文献
108.
Kayoko Kasuya Yusuke Kawamura Masahiro Kobayashi Junichi Shindoh Yuta Kobayashi Akira Kajiwara Soichi Iritani Shunichiro Fujiyama Tetsuya Hosaka Satoshi Saitoh Hitomi Sezaki Norio Akuta Fumitaka Suzuki Yoshiyuki Suzuki Kenji Ikeda Yasuji Arase Yuichiro Eguchi Masaji Hashimoto Hiromitsu Kumada 《Internal medicine (Tokyo, Japan)》2021,60(3):345
Objective A survival benefit was demonstrated for ramucirumab (RAM) in patients with unresectable hepatocellular carcinoma (uHCC) and α-fetoprotein (AFP) concentrations ≥400 ng/mL who had previously received sorafenib (SOR). However, it is unclear whether RAM has a similar efficacy in patients with uHCC that progresses after lenvatinib (LEN) treatment. This study aimed to evaluate the early anti-tumor response to RAM as a second-line treatment for advanced uHCC after LEN treatment. Methods We retrospectively assessed the efficacy and safety of RAM at 6 weeks after initiation. The therapeutic effects were evaluated according to the Response Evaluation Criteria in Solid Tumors version 1.1. Patients We evaluated 7 patients with uHCC who received RAM as a second- or third-line treatment after LEN failure. Results The disease control rate (DCR) was 28.6% (2 of 7 patients). After the initiation of RAM, a rapid disease progression resulted in 1 patient death after 19 days. The median progression-free survival (PFS) was 41 days. There were no grade 3 or 4 treatment-related adverse events. At 6 weeks, there was no deterioration in the modified albumin-bilirubin (mALBI) grade. In patients with an imaging response of stable disease (SD), the rate of AFP production decreased from the baseline. Conclusion RAM may have a therapeutic potential for the suppression of uHCC progression in patients previously treated with LEN, as well as for maintaining the liver function during treatment. Evaluating the AFP trends may therefore be useful for predicting RAM effectiveness. 相似文献
109.
110.